Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shengyu Decoction + Manipulation for Knee OA
NCT06451783Phase 1Enrolling by invitation
- Sponsor
- Shanghai Xuhui District Central Hospital
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised trial of Shengyu Decoction in osteoarthritis (OA) (2 arms), sponsored by Shanghai Xuhui District Central Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 13 weeks. Started May 2024; status: enrolling by invitation.
02
Drugs
Shengyu Decoction
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06451783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451783.